Fox Run Management’s Zimmer Biomet ZBH Stock Holding History

Fox Run Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,803	Closed	-$276K	–	1317
2025 Q3	$276K	Buy	+2,803	New	+$278K	0.04%	711
2024 Q2	–	Sell	-8,135	Closed	-$1.07M	–	1121
2024 Q1	$1.07M	Buy	+8,135	New	+$1.02M	0.23%	108
2023 Q4	–	Sell	-4,406	Closed	-$494K	–	1060
2023 Q3	$494K	Buy	+4,406	New	+$560K	0.15%	265
2023 Q2	–	Sell	-2,349	Closed	-$303K	–	1009
2023 Q1	$303K	Sell	2,349 -3,973	-63%	-$499K	0.1%	398
2022 Q4	$806K	Buy	+6,322	New	+$734K	0.32%	46
2020 Q2	–	Sell	-2,406	Closed	-$236K	–	324
2020 Q1	$236K	Buy	+2,406	New	+$315K	0.56%	59
2019 Q3	–	Sell	-3,880	Closed	-$444K	–	592
2019 Q2	$444K	Buy	+3,880	New	+$454K	0.29%	104
2017 Q2	–	Sell	-1,957	Closed	-$232K	–	866
2017 Q1	$232K	Buy	+1,957	New	+$222K	0.09%	453
2016 Q2	–	Sell	-6,283	Closed	-$650K	–	694
2016 Q1	$650K	Buy	+6,283	New	+$608K	0.43%	34

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Fox Run Management's ZBH Position: Q4 2025 in Review

Fox Run Management sold out of Zimmer Biomet (ZBH) in Q4 2025, closing a stake of 2,803 shares — an estimated $276K sold.

Fox Run Management first reported a position in ZBH in Q1 2016 and held it in 9 quarters. The position peaked at $1.07M in Q1 2024. 947 funds tracked by Wall St. Rank hold ZBH as of Q4 2025.

Fox Run Management reported no remaining Zimmer Biomet position as of Q4 2025 after selling out during the quarter.
Fox Run Management sold 2,803 Zimmer Biomet shares in Q4 2025, an estimated $276K.
Fox Run Management first reported a position in Zimmer Biomet in Q1 2016 and held it in 9 quarters.
Fox Run Management's Zimmer Biomet position peaked at $1.07M in Q1 2024.
947 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2025.

Based on Fox Run Management's 13F filing for Q4 2025, filed 11 Feb 2026.